Synthetic high concentration Abeta oligomer preparations contain significant amounts of monomer when analyzed via western blot (Fig. 2A) or quantified via two-site and single-site binding ELISAs (Table 1 and references [5], [39]), whereas human AD patient-derived Abeta does not. The gene discussed is APP; the disease is Alzheimer disease.